Brief: Aeterna Zentaris Q4 Loss Per Share $0.31
March 26 (Reuters) - Aeterna Zentaris Inc AEZS.TO :
* AETERNA ZENTARIS REPORTS FOURTH QUARTER AND FULL-YEAR 2018
FINANCIAL AND OPERATING RESULTS
* Q4 LOSS PER SHARE $0.31
* TOTAL REVENUE FOR Q4 2018 WAS $1.4 MILLION, COMPARED TO
$0.2
MILLION FOR Q4 2017
* AS OF DECEMBER 31, 2018, CO HAD $14.5 MILLION OF
UNRESTRICTED
CASH AND CASH EQUIVALENTS
Source text for Eikon: ID:nGNX5Jrn8y
Further company coverage: AEZS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on COSCIENS Biopharma
See all newsBrief: COSCIENS Acquires Nualtis Corp
Refile: Canada's COSCIENS Biopharma Q2 net loss narrows on higher sales
Canada's COSCIENS Biopharma Q1 net income turns positive on discontinued German operations
Brief: Cosciens Biopharma Inc Not Aware Of Material Undisclosed Information Amid Recent Trading Activity
Brief: Cosciens Provides Strategic Update